| 1 | its | 58,865 |
| 2 | ferric-reducing | 25 |
| 3 | polysome | 12 |
| 4 | pentanisia | 9 |
| 5 | perovskia | 6 |
| 6 | methylepicatechin | 4 |
| 7 | perlite-based | 4 |
| 8 | cgmp-independent | 3 |
| 9 | gender-predicted | 3 |
| 10 | metabolical | 3 |
| 11 | mycobacterial-specific | 3 |
| 12 | paraseptal | 3 |
| 13 | undirect | 3 |
| 14 | 'proven | 2 |
| 15 | 'reserva | 2 |
| 16 | aldosterone-secreting | 2 |
| 17 | asymptotical | 2 |
| 18 | camkii/tak1 | 2 |
| 19 | desfuroylceftiofur-related | 2 |
| 20 | dyadic-level | 2 |
| 21 | gabaa-mediated | 2 |
| 22 | haralick | 2 |
| 23 | kampo-derived | 2 |
| 24 | mpo-induced | 2 |
| 25 | nevirapine-protein | 2 |
| 26 | non-phototoxic | 2 |
| 27 | port-a-cath-related | 2 |
| 28 | shared-use | 2 |
| 29 | thermal-control | 2 |
| 30 | vasopermeability | 2 |
| 31 | 'biologic | 1 |
| 32 | -operated | 1 |
| 33 | -width | 1 |
| 34 | 11,783 | 1 |
| 35 | 2,547.7 | 1 |
| 36 | 25,463 | 1 |
| 37 | 29,782 | 1 |
| 38 | 3,6-dihydro-1,2-oxazine | 1 |
| 39 | 3-mp-stimulated | 1 |
| 40 | 34,316 | 1 |
| 41 | 34,539 | 1 |
| 42 | 397,534 | 1 |
| 43 | 3α,5β-reduced | 1 |
| 44 | 4'-o-methyl-epicatechin | 1 |
| 45 | 4-hydroxyatorvastatin | 1 |
| 46 | 432,655 | 1 |
| 47 | 50,048 | 1 |
| 48 | 54,499 | 1 |
| 49 | 7,934 | 1 |
| 50 | 7-o-luteolin | 1 |
| 51 | 7.5±3.8 | 1 |
| 52 | 8630 | 1 |
| 53 | advanced-lesion | 1 |
| 54 | alpha-motoneuronal | 1 |
| 55 | angiopoiesis | 1 |
| 56 | anti-sialorrhea | 1 |
| 57 | antinecrotic | 1 |
| 58 | anxiety-induced | 1 |
| 59 | apelin-ar | 1 |
| 60 | asd-id | 1 |
| 61 | attachment-emotion | 1 |
| 62 | bfa1-centrosome | 1 |
| 63 | butenolide-based | 1 |
| 64 | care-seeker | 1 |
| 65 | caryopsis-specific | 1 |
| 66 | cd3+cd16/cd56+ | 1 |
| 67 | cd3-/cd56+ | 1 |
| 68 | changbaishan | 1 |
| 69 | cholestero-lowering | 1 |
| 70 | client-focused | 1 |
| 71 | clindamycin-related | 1 |
| 72 | clinical/bacterial | 1 |
| 73 | clinical/experimental | 1 |
| 74 | cognitive-attentional | 1 |
| 75 | color-rendering | 1 |
| 76 | cross-situational | 1 |
| 77 | cultural/religious | 1 |
| 78 | cvd.77 | 1 |
| 79 | cyp2c9-specific | 1 |
| 80 | d2-r-binding | 1 |
| 81 | d6-m1 | 1 |
| 82 | dehydrodehydrocostus | 1 |
| 83 | di-dmt | 1 |
| 84 | dicyanomethylene | 1 |
| 85 | durative | 1 |
| 86 | embryostatic | 1 |
| 87 | enantiodivergent | 1 |
| 88 | endotaxial | 1 |
| 89 | envirotechnical | 1 |
| 90 | epoxide-containing | 1 |
| 91 | equivalent/lower | 1 |
| 92 | ethno-sociologic | 1 |
| 93 | extracellular-matrix-binding | 1 |
| 94 | fea-determined | 1 |
| 95 | forest-based | 1 |
| 96 | foxo1/mkp-3 | 1 |
| 97 | fracture-reducing | 1 |
| 98 | geniposide-time-antioxidant | 1 |
| 99 | gingivitis-reducing | 1 |
| 100 | glutathione-mediated | 1 |
| 101 | goldenseal׳s | 1 |
| 102 | gpd1-mediated | 1 |
| 103 | gps.the | 1 |
| 104 | gαi2-rgs12 | 1 |
| 105 | haemothorax/pneumothorax | 1 |
| 106 | hasthe | 1 |
| 107 | health-giving | 1 |
| 108 | hepatic/enteric-derived | 1 |
| 109 | hepato-nephro | 1 |
| 110 | hrql-based | 1 |
| 111 | hsf-1-regulated | 1 |
| 112 | hydroxytrosol | 1 |
| 113 | hyperpotassemic | 1 |
| 114 | il-22-expressing | 1 |
| 115 | imatinib-related | 1 |
| 116 | inflammatory/irritant | 1 |
| 117 | internanoparticle | 1 |
| 118 | intervention-dependent | 1 |
| 119 | j-coupled | 1 |
| 120 | jak3-dependent | 1 |
| 121 | lesion-depiction | 1 |
| 122 | lung-stage | 1 |
| 123 | m-xylyl-ring | 1 |
| 124 | meperidine-sparing | 1 |
| 125 | metalloenzyme-based | 1 |
| 126 | microrna-associated | 1 |
| 127 | minimal-invasiveness | 1 |
| 128 | mtor-targeted | 1 |
| 129 | multi-differentiation | 1 |
| 130 | multi-generational | 1 |
| 131 | multi-target-point | 1 |
| 132 | muscle-protective | 1 |
| 133 | n-butyryl-l-homoserine | 1 |
| 134 | n-hexanoyl-l-homoserine | 1 |
| 135 | nephron-protective | 1 |
| 136 | non-concentration-related | 1 |
| 137 | non-photoactive | 1 |
| 138 | nonflexible | 1 |
| 139 | nrf2-induced | 1 |
| 140 | nsaid/aspirin | 1 |
| 141 | organizational.the | 1 |
| 142 | outcomes-driven | 1 |
| 143 | oxcarbazepine.the | 1 |
| 144 | p50-101 | 1 |
| 145 | patientís | 1 |
| 146 | peakless | 1 |
| 147 | perforin-producing | 1 |
| 148 | persistenzt | 1 |
| 149 | phagocytosis-independent | 1 |
| 150 | pick1-mediated | 1 |
| 151 | placodal | 1 |
| 152 | polycomb-mediated | 1 |
| 153 | polymorphism-independent | 1 |
| 154 | polyreactive | 1 |
| 155 | psychological/behavioral | 1 |
| 156 | quinone-induced | 1 |
| 157 | r-desmethyl | 1 |
| 158 | recurrence/new | 1 |
| 159 | redox-linked | 1 |
| 160 | rehabilitation.before | 1 |
| 161 | revolutionaries | 1 |
| 162 | ring-remaining | 1 |
| 163 | salmonella-killing | 1 |
| 164 | scalp-related | 1 |
| 165 | schedule-defined | 1 |
| 166 | statistic1.0 | 1 |
| 167 | suberin-like | 1 |
| 168 | t-acceptor | 1 |
| 169 | teratogenesis-promoting | 1 |
| 170 | thioacylenzyme | 1 |
| 171 | threat-induced | 1 |
| 172 | training-corrected | 1 |
| 173 | treatment-shortening | 1 |
| 174 | tube-forming | 1 |
| 175 | tumor‑initiating | 1 |
| 176 | tumour-forming | 1 |
| 177 | tumour-suppressive | 1 |
| 178 | unstable-closed | 1 |
| 179 | urate-elevating | 1 |
| 180 | valproatethe | 1 |
| 181 | vehicle-toward-drug | 1 |
| 182 | visuospacial | 1 |
| 183 | vrti-episode | 1 |
| 184 | x2/x3 | 1 |
| 185 | xiap-deficient | 1 |
| 186 | zoo-derived | 1 |
| 187 | ¹³c-¹³c/¹³c-¹²c | 1 |
| 1 | 'biologic | 1 |
| 2 | 'proven | 2 |
| 3 | 'reserva | 2 |
| 4 | -operated | 1 |
| 5 | -width | 1 |
| 6 | 11,783 | 1 |
| 7 | 2,547.7 | 1 |
| 8 | 25,463 | 1 |
| 9 | 29,782 | 1 |
| 10 | 3,6-dihydro-1,2-oxazine | 1 |
| 11 | 3-mp-stimulated | 1 |
| 12 | 34,316 | 1 |
| 13 | 34,539 | 1 |
| 14 | 397,534 | 1 |
| 15 | 3α,5β-reduced | 1 |
| 16 | 4'-o-methyl-epicatechin | 1 |
| 17 | 4-hydroxyatorvastatin | 1 |
| 18 | 432,655 | 1 |
| 19 | 50,048 | 1 |
| 20 | 54,499 | 1 |
| 21 | 7,934 | 1 |
| 22 | 7-o-luteolin | 1 |
| 23 | 7.5±3.8 | 1 |
| 24 | 8630 | 1 |
| 25 | advanced-lesion | 1 |
| 26 | aldosterone-secreting | 2 |
| 27 | alpha-motoneuronal | 1 |
| 28 | angiopoiesis | 1 |
| 29 | anti-sialorrhea | 1 |
| 30 | antinecrotic | 1 |
| 31 | anxiety-induced | 1 |
| 32 | apelin-ar | 1 |
| 33 | asd-id | 1 |
| 34 | asymptotical | 2 |
| 35 | attachment-emotion | 1 |
| 36 | bfa1-centrosome | 1 |
| 37 | butenolide-based | 1 |
| 38 | camkii/tak1 | 2 |
| 39 | care-seeker | 1 |
| 40 | caryopsis-specific | 1 |
| 41 | cd3+cd16/cd56+ | 1 |
| 42 | cd3-/cd56+ | 1 |
| 43 | cgmp-independent | 3 |
| 44 | changbaishan | 1 |
| 45 | cholestero-lowering | 1 |
| 46 | client-focused | 1 |
| 47 | clindamycin-related | 1 |
| 48 | clinical/bacterial | 1 |
| 49 | clinical/experimental | 1 |
| 50 | cognitive-attentional | 1 |
| 51 | color-rendering | 1 |
| 52 | cross-situational | 1 |
| 53 | cultural/religious | 1 |
| 54 | cvd.77 | 1 |
| 55 | cyp2c9-specific | 1 |
| 56 | d2-r-binding | 1 |
| 57 | d6-m1 | 1 |
| 58 | dehydrodehydrocostus | 1 |
| 59 | desfuroylceftiofur-related | 2 |
| 60 | di-dmt | 1 |
| 61 | dicyanomethylene | 1 |
| 62 | durative | 1 |
| 63 | dyadic-level | 2 |
| 64 | embryostatic | 1 |
| 65 | enantiodivergent | 1 |
| 66 | endotaxial | 1 |
| 67 | envirotechnical | 1 |
| 68 | epoxide-containing | 1 |
| 69 | equivalent/lower | 1 |
| 70 | ethno-sociologic | 1 |
| 71 | extracellular-matrix-binding | 1 |
| 72 | fea-determined | 1 |
| 73 | ferric-reducing | 25 |
| 74 | forest-based | 1 |
| 75 | foxo1/mkp-3 | 1 |
| 76 | fracture-reducing | 1 |
| 77 | gabaa-mediated | 2 |
| 78 | gender-predicted | 3 |
| 79 | geniposide-time-antioxidant | 1 |
| 80 | gingivitis-reducing | 1 |
| 81 | glutathione-mediated | 1 |
| 82 | goldenseal׳s | 1 |
| 83 | gpd1-mediated | 1 |
| 84 | gps.the | 1 |
| 85 | gαi2-rgs12 | 1 |
| 86 | haemothorax/pneumothorax | 1 |
| 87 | haralick | 2 |
| 88 | hasthe | 1 |
| 89 | health-giving | 1 |
| 90 | hepatic/enteric-derived | 1 |
| 91 | hepato-nephro | 1 |
| 92 | hrql-based | 1 |
| 93 | hsf-1-regulated | 1 |
| 94 | hydroxytrosol | 1 |
| 95 | hyperpotassemic | 1 |
| 96 | il-22-expressing | 1 |
| 97 | imatinib-related | 1 |
| 98 | inflammatory/irritant | 1 |
| 99 | internanoparticle | 1 |
| 100 | intervention-dependent | 1 |
| 101 | its | 58,865 |
| 102 | j-coupled | 1 |
| 103 | jak3-dependent | 1 |
| 104 | kampo-derived | 2 |
| 105 | lesion-depiction | 1 |
| 106 | lung-stage | 1 |
| 107 | m-xylyl-ring | 1 |
| 108 | meperidine-sparing | 1 |
| 109 | metabolical | 3 |
| 110 | metalloenzyme-based | 1 |
| 111 | methylepicatechin | 4 |
| 112 | microrna-associated | 1 |
| 113 | minimal-invasiveness | 1 |
| 114 | mpo-induced | 2 |
| 115 | mtor-targeted | 1 |
| 116 | multi-differentiation | 1 |
| 117 | multi-generational | 1 |
| 118 | multi-target-point | 1 |
| 119 | muscle-protective | 1 |
| 120 | mycobacterial-specific | 3 |
| 121 | n-butyryl-l-homoserine | 1 |
| 122 | n-hexanoyl-l-homoserine | 1 |
| 123 | nephron-protective | 1 |
| 124 | nevirapine-protein | 2 |
| 125 | non-concentration-related | 1 |
| 126 | non-photoactive | 1 |
| 127 | non-phototoxic | 2 |
| 128 | nonflexible | 1 |
| 129 | nrf2-induced | 1 |
| 130 | nsaid/aspirin | 1 |
| 131 | organizational.the | 1 |
| 132 | outcomes-driven | 1 |
| 133 | oxcarbazepine.the | 1 |
| 134 | p50-101 | 1 |
| 135 | paraseptal | 3 |
| 136 | patientís | 1 |
| 137 | peakless | 1 |
| 138 | pentanisia | 9 |
| 139 | perforin-producing | 1 |
| 140 | perlite-based | 4 |
| 141 | perovskia | 6 |
| 142 | persistenzt | 1 |
| 143 | phagocytosis-independent | 1 |
| 144 | pick1-mediated | 1 |
| 145 | placodal | 1 |
| 146 | polycomb-mediated | 1 |
| 147 | polymorphism-independent | 1 |
| 148 | polyreactive | 1 |
| 149 | polysome | 12 |
| 150 | port-a-cath-related | 2 |
| 151 | psychological/behavioral | 1 |
| 152 | quinone-induced | 1 |
| 153 | r-desmethyl | 1 |
| 154 | recurrence/new | 1 |
| 155 | redox-linked | 1 |
| 156 | rehabilitation.before | 1 |
| 157 | revolutionaries | 1 |
| 158 | ring-remaining | 1 |
| 159 | salmonella-killing | 1 |
| 160 | scalp-related | 1 |
| 161 | schedule-defined | 1 |
| 162 | shared-use | 2 |
| 163 | statistic1.0 | 1 |
| 164 | suberin-like | 1 |
| 165 | t-acceptor | 1 |
| 166 | teratogenesis-promoting | 1 |
| 167 | thermal-control | 2 |
| 168 | thioacylenzyme | 1 |
| 169 | threat-induced | 1 |
| 170 | training-corrected | 1 |
| 171 | treatment-shortening | 1 |
| 172 | tube-forming | 1 |
| 173 | tumor‑initiating | 1 |
| 174 | tumour-forming | 1 |
| 175 | tumour-suppressive | 1 |
| 176 | undirect | 3 |
| 177 | unstable-closed | 1 |
| 178 | urate-elevating | 1 |
| 179 | valproatethe | 1 |
| 180 | vasopermeability | 2 |
| 181 | vehicle-toward-drug | 1 |
| 182 | visuospacial | 1 |
| 183 | vrti-episode | 1 |
| 184 | x2/x3 | 1 |
| 185 | xiap-deficient | 1 |
| 186 | zoo-derived | 1 |
| 187 | ¹³c-¹³c/¹³c-¹²c | 1 |
| 1 | cd3-/cd56+ | 1 |
| 2 | cd3+cd16/cd56+ | 1 |
| 3 | statistic1.0 | 1 |
| 4 | 8630 | 1 |
| 5 | p50-101 | 1 |
| 6 | camkii/tak1 | 2 |
| 7 | d6-m1 | 1 |
| 8 | gαi2-rgs12 | 1 |
| 9 | 29,782 | 1 |
| 10 | foxo1/mkp-3 | 1 |
| 11 | 25,463 | 1 |
| 12 | 11,783 | 1 |
| 13 | x2/x3 | 1 |
| 14 | 397,534 | 1 |
| 15 | 7,934 | 1 |
| 16 | 432,655 | 1 |
| 17 | 34,316 | 1 |
| 18 | 2,547.7 | 1 |
| 19 | cvd.77 | 1 |
| 20 | 7.5±3.8 | 1 |
| 21 | 50,048 | 1 |
| 22 | 34,539 | 1 |
| 23 | 54,499 | 1 |
| 24 | anti-sialorrhea | 1 |
| 25 | perovskia | 6 |
| 26 | pentanisia | 9 |
| 27 | 'reserva | 2 |
| 28 | cyp2c9-specific | 1 |
| 29 | mycobacterial-specific | 3 |
| 30 | caryopsis-specific | 1 |
| 31 | 'biologic | 1 |
| 32 | ethno-sociologic | 1 |
| 33 | hyperpotassemic | 1 |
| 34 | embryostatic | 1 |
| 35 | antinecrotic | 1 |
| 36 | non-phototoxic | 2 |
| 37 | ¹³c-¹³c/¹³c-¹²c | 1 |
| 38 | 3α,5β-reduced | 1 |
| 39 | nrf2-induced | 1 |
| 40 | quinone-induced | 1 |
| 41 | mpo-induced | 2 |
| 42 | threat-induced | 1 |
| 43 | anxiety-induced | 1 |
| 44 | redox-linked | 1 |
| 45 | j-coupled | 1 |
| 46 | schedule-defined | 1 |
| 47 | fea-determined | 1 |
| 48 | butenolide-based | 1 |
| 49 | metalloenzyme-based | 1 |
| 50 | perlite-based | 4 |
| 51 | hrql-based | 1 |
| 52 | forest-based | 1 |
| 53 | unstable-closed | 1 |
| 54 | client-focused | 1 |
| 55 | microrna-associated | 1 |
| 56 | gpd1-mediated | 1 |
| 57 | pick1-mediated | 1 |
| 58 | gabaa-mediated | 2 |
| 59 | polycomb-mediated | 1 |
| 60 | glutathione-mediated | 1 |
| 61 | imatinib-related | 1 |
| 62 | port-a-cath-related | 2 |
| 63 | clindamycin-related | 1 |
| 64 | non-concentration-related | 1 |
| 65 | scalp-related | 1 |
| 66 | desfuroylceftiofur-related | 2 |
| 67 | hsf-1-regulated | 1 |
| 68 | 3-mp-stimulated | 1 |
| 69 | -operated | 1 |
| 70 | training-corrected | 1 |
| 71 | gender-predicted | 3 |
| 72 | mtor-targeted | 1 |
| 73 | hepatic/enteric-derived | 1 |
| 74 | zoo-derived | 1 |
| 75 | kampo-derived | 2 |
| 76 | asd-id | 1 |
| 77 | vrti-episode | 1 |
| 78 | lung-stage | 1 |
| 79 | oxcarbazepine.the | 1 |
| 80 | organizational.the | 1 |
| 81 | gps.the | 1 |
| 82 | valproatethe | 1 |
| 83 | hasthe | 1 |
| 84 | suberin-like | 1 |
| 85 | nonflexible | 1 |
| 86 | internanoparticle | 1 |
| 87 | bfa1-centrosome | 1 |
| 88 | polysome | 12 |
| 89 | thioacylenzyme | 1 |
| 90 | dicyanomethylene | 1 |
| 91 | n-hexanoyl-l-homoserine | 1 |
| 92 | n-butyryl-l-homoserine | 1 |
| 93 | 3,6-dihydro-1,2-oxazine | 1 |
| 94 | rehabilitation.before | 1 |
| 95 | shared-use | 2 |
| 96 | tumour-suppressive | 1 |
| 97 | durative | 1 |
| 98 | polyreactive | 1 |
| 99 | non-photoactive | 1 |
| 100 | muscle-protective | 1 |
| 101 | nephron-protective | 1 |
| 102 | ferric-reducing | 25 |
| 103 | fracture-reducing | 1 |
| 104 | gingivitis-reducing | 1 |
| 105 | perforin-producing | 1 |
| 106 | d2-r-binding | 1 |
| 107 | extracellular-matrix-binding | 1 |
| 108 | salmonella-killing | 1 |
| 109 | tube-forming | 1 |
| 110 | tumour-forming | 1 |
| 111 | treatment-shortening | 1 |
| 112 | ring-remaining | 1 |
| 113 | epoxide-containing | 1 |
| 114 | m-xylyl-ring | 1 |
| 115 | meperidine-sparing | 1 |
| 116 | color-rendering | 1 |
| 117 | cholestero-lowering | 1 |
| 118 | il-22-expressing | 1 |
| 119 | tumor‑initiating | 1 |
| 120 | urate-elevating | 1 |
| 121 | aldosterone-secreting | 2 |
| 122 | teratogenesis-promoting | 1 |
| 123 | health-giving | 1 |
| 124 | vehicle-toward-drug | 1 |
| 125 | -width | 1 |
| 126 | haralick | 2 |
| 127 | metabolical | 3 |
| 128 | envirotechnical | 1 |
| 129 | asymptotical | 2 |
| 130 | placodal | 1 |
| 131 | visuospacial | 1 |
| 132 | clinical/bacterial | 1 |
| 133 | endotaxial | 1 |
| 134 | multi-generational | 1 |
| 135 | cross-situational | 1 |
| 136 | cognitive-attentional | 1 |
| 137 | alpha-motoneuronal | 1 |
| 138 | psychological/behavioral | 1 |
| 139 | clinical/experimental | 1 |
| 140 | paraseptal | 3 |
| 141 | dyadic-level | 2 |
| 142 | thermal-control | 2 |
| 143 | hydroxytrosol | 1 |
| 144 | r-desmethyl | 1 |
| 145 | changbaishan | 1 |
| 146 | outcomes-driven | 1 |
| 147 | 'proven | 2 |
| 148 | nevirapine-protein | 2 |
| 149 | 4'-o-methyl-epicatechin | 1 |
| 150 | methylepicatechin | 4 |
| 151 | 7-o-luteolin | 1 |
| 152 | nsaid/aspirin | 1 |
| 153 | 4-hydroxyatorvastatin | 1 |
| 154 | advanced-lesion | 1 |
| 155 | multi-differentiation | 1 |
| 156 | lesion-depiction | 1 |
| 157 | attachment-emotion | 1 |
| 158 | hepato-nephro | 1 |
| 159 | apelin-ar | 1 |
| 160 | care-seeker | 1 |
| 161 | equivalent/lower | 1 |
| 162 | t-acceptor | 1 |
| 163 | revolutionaries | 1 |
| 164 | angiopoiesis | 1 |
| 165 | peakless | 1 |
| 166 | minimal-invasiveness | 1 |
| 167 | its | 58,865 |
| 168 | cultural/religious | 1 |
| 169 | dehydrodehydrocostus | 1 |
| 170 | patientís | 1 |
| 171 | goldenseal׳s | 1 |
| 172 | undirect | 3 |
| 173 | di-dmt | 1 |
| 174 | geniposide-time-antioxidant | 1 |
| 175 | inflammatory/irritant | 1 |
| 176 | jak3-dependent | 1 |
| 177 | intervention-dependent | 1 |
| 178 | polymorphism-independent | 1 |
| 179 | cgmp-independent | 3 |
| 180 | phagocytosis-independent | 1 |
| 181 | enantiodivergent | 1 |
| 182 | xiap-deficient | 1 |
| 183 | multi-target-point | 1 |
| 184 | persistenzt | 1 |
| 185 | recurrence/new | 1 |
| 186 | haemothorax/pneumothorax | 1 |
| 187 | vasopermeability | 2 |